Arcturus Therapeutics Holdings (ARCT) Return on Invested Capital (2023 - 2025)

Arcturus Therapeutics Holdings has reported Return on Invested Capital for 3 years, with the latest figure at 0.0% in Q2 2025.

• For the quarter ending Q2 2025, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Jun 2025 stood at 0.0% (changed 0.0% YoY), and the FY2024 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital for Q2 2025 stood at 0.0%, up from 0.0% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.0% in Q3 2023, with the low at 0.0% in Q1 2024.
• Historically, Return on Invested Capital has averaged 0.0% across 3 years, with a median of 0.0% in 2025.
• The largest YoY upside for Return on Invested Capital was 0 bps in 2024 against a maximum downside of 1 bps in 2024.
• Arcturus Therapeutics Holdings' Return on Invested Capital stood at 0.0% in 2023, then declined by 28 bps to 0.0% in 2024, then grew by 18 bps to 0.0% in 2025.
• The last three Return on Invested Capital figures came in at 0.0% (Q2 2025), 0.0% (Q1 2025), and 0.0% (Q4 2024), per Business Quant data.